COVID-19: Subject Expert Committee seeks DCGI's nod to use hepatitis injection for phase III clinical trial
Aug 19, 2020
New Delhi [India], Aug 19 : The Subject Expert Committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) has recommended that the country's top drug regulator grant permission for phase 3 clinical trial using Thymosin @-1 injection 1.6 mg on moderate to severe COVID-19 patients, said a senior health ministry official on Wednesday.